Pharmacoprevention for hereditary breast and ovarian cancer

Massimiliano Cazzaniga; Bernardo Bonanni

Pharmacoprevention for hereditary breast and ovarian cancer

Massimiliano Cazzaniga, Bernardo Bonanni

Istituto Europeo di Oncologia

Research output: Contribution to journal › Review article › peer-review

Abstract

Hereditary breast and ovarian cancer (HBOC) syndrome is an important women's health condition characterized by an increased susceptibility to the development of cancer, in particular breast and ovarian neoplasms, and is caused by an inherited germline genetic mutation in one or both tumor suppressor genes named BRCA1 and BRCA2. This monographic issue provides an update on our knowledge of this syndrome with particular emphasis on the risk reduction strategies through a pharmacopreventive approach.

Original language	English
Pages (from-to)	517-535
Number of pages	19
Journal	Minerva Ginecologica
Volume	68
Issue number	5
Publication status	Published - Oct 1 2016

Keywords

Chemoprevention
Germ-line mutation
Hereditary breast and ovarian cancer syndrome

ASJC Scopus subject areas

Obstetrics and Gynaecology

Access to Document

Fingerprint Dive into the research topics of 'Pharmacoprevention for hereditary breast and ovarian cancer'. Together they form a unique fingerprint.

Cite this

@article{0306e73c5f6c4148a1b79a7d45440b87,

title = "Pharmacoprevention for hereditary breast and ovarian cancer",

abstract = "Hereditary breast and ovarian cancer (HBOC) syndrome is an important women's health condition characterized by an increased susceptibility to the development of cancer, in particular breast and ovarian neoplasms, and is caused by an inherited germline genetic mutation in one or both tumor suppressor genes named BRCA1 and BRCA2. This monographic issue provides an update on our knowledge of this syndrome with particular emphasis on the risk reduction strategies through a pharmacopreventive approach.",

keywords = "Chemoprevention, Germ-line mutation, Hereditary breast and ovarian cancer syndrome",

author = "Massimiliano Cazzaniga and Bernardo Bonanni",

year = "2016",

month = oct,

day = "1",

language = "English",

volume = "68",

pages = "517--535",

journal = "Minerva Ginecologica",

issn = "0026-4784",

publisher = "Edizioni Minerva Medica S.p.A.",

number = "5",

}

TY - JOUR

T1 - Pharmacoprevention for hereditary breast and ovarian cancer

AU - Cazzaniga, Massimiliano

AU - Bonanni, Bernardo

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Hereditary breast and ovarian cancer (HBOC) syndrome is an important women's health condition characterized by an increased susceptibility to the development of cancer, in particular breast and ovarian neoplasms, and is caused by an inherited germline genetic mutation in one or both tumor suppressor genes named BRCA1 and BRCA2. This monographic issue provides an update on our knowledge of this syndrome with particular emphasis on the risk reduction strategies through a pharmacopreventive approach.

AB - Hereditary breast and ovarian cancer (HBOC) syndrome is an important women's health condition characterized by an increased susceptibility to the development of cancer, in particular breast and ovarian neoplasms, and is caused by an inherited germline genetic mutation in one or both tumor suppressor genes named BRCA1 and BRCA2. This monographic issue provides an update on our knowledge of this syndrome with particular emphasis on the risk reduction strategies through a pharmacopreventive approach.

KW - Chemoprevention

KW - Germ-line mutation

KW - Hereditary breast and ovarian cancer syndrome

UR - http://www.scopus.com/inward/record.url?scp=84983611746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983611746&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:84983611746

VL - 68

SP - 517

EP - 535

JO - Minerva Ginecologica

JF - Minerva Ginecologica

SN - 0026-4784

IS - 5

ER -